AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
25. November 2024 16:02 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care...
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
12. November 2024 16:03 ET
|
AVITA Medical
AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
01. August 2024 16:05 ET
|
AVITA Medical
AVITA Medical announces industry leader, Robin VanDenburgh, has joined as Senior Vice President of U.S. Commercial Sales, effective August 6, 2024.
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
31. Juli 2024 16:05 ET
|
AVITA Medical
AVITA Medical expands portfolio with unique collagen dermal matrix through an exclusive development and distribution agreement with Regenity Biosciences.
AVITA Medical Achieves Milestone with First Case Using RECELL GO
05. Juni 2024 16:25 ET
|
AVITA Medical
Joseph M. Still Burn Center at Doctors Hospital of Augusta treats first patient using AVITA Medical’s FDA-Approved RECELL GO System.
AVITA Medical Announces FDA Approval of RECELL GO
30. Mai 2024 09:15 ET
|
AVITA Medical
AVITA Medical receives FDA approval for RECELL GO, its next-generation device used to treat thermal burn wounds and full thickness skin defects.
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
29. Februar 2024 16:02 ET
|
AVITA Medical
AVITA Medical submitted its response to FDA for additional information in connection to RECELL GO PMA supplement. Submission resumes substantive review.